Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Headlines > Novartis, Roche near US drug price deal, Bloomberg News reports

Headlines

Novartis, Roche near US drug price deal, Bloomberg News reports

Published by Global Banking and Finance Review

Posted on December 17, 2025

Featured image for article about Headlines

Dec ‌17 (Reuters) - ‍The ‌White House is ⁠set ‌to announce ⁠drug pricing deals with pharmaceutical ‌heavyweights ⁠Novartis AG and Roche Holding AG as soon as ‍Friday, Bloomberg News reported on Wednesday citing ⁠people familiar with the situation.

(Reporting by ‌Sriparna Roy in Bengaluru)

More from Headlines

Explore more articles in the Headlines category

UK's Inocea Group eyes acquisition of Germany warship builder GNYK, source says

US allows oil sales from Russia's Sakhalin-2 project through June 18

UK exempts Egypt's Zohr gas field from Russia sanctions

ECB proposes extending Elderson's mandate at bank supervision arm

Exclusive-Poland to start producing anti-personnel mines to lay along eastern border

German budget committee clears 50 billion euros in defence contracts

Germany opens joint drone defence centre in Berlin

Finland's prime minister apologises to Asian nations over racism scandal

Spanish city evicts hundreds of migrants from occupied building

US confirms tariff elements of trade deal with Switzerland

Swedish explosives start-up gets permit for TNT factory

US gaming platform Roblox pledges changes to get Russian ban lifted

View All Headlines Posts